CADTH | Evidence Driven
CADTH | Evidence Driven

Creatinine and Urea Point of Care Testing for Patients with Suspected Renal Failure: Clinical Utility, Cost-Effectiveness and Guidelines

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1465-000

Question

  1. What is the clinical utility of creatinine and urea point of care testing for patients with suspected renal failure?
  2. What is the cost-effectiveness of creatinine and urea point of care testing for patients with suspected renal failure?
  3. What are the evidence-based guidelines regarding the use of creatinine and urea point of care testing in non-emergency department settings?

Key Message

Four non-randomized studies were identified regarding the clinical utility of creatinine and urea point of care testing with suspected renal failure or impairment. One evidence-based guideline was identified regarding the use of creatinine and urea point of care testing in non-emergency department settings. No economic evaluations were identified regarding the cost-effectiveness of creatinine and urea point of care testing for patients with suspected renal failure.

Files

Creatinine and Urea Point of Care Testing for Patients with Suspected Renal Failure: Clinical Utility, Cost-Effectiveness and Guidelines Rapid Response April 15, 2020 View PDF

Related Content

Last Updated : April 20, 2020